News | News By Subject | News by Disease News By Date | Search News

Angina / Ischemic heart disease News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Gilead Sciences, Inc. (GILD) Drug Reduces Chest Pain Episodes in Diabetics: Study     3/11/2013
Ischemix Announces Positive Top Line Data from Phase 2 Clinical Trial of CMX-2043     6/17/2011
CV Therapeutics, Inc. (CVTX): FDA to Review Additional Use of Angina Drug     12/7/2007
New Data Reassures on CV Therapeutics, Inc. (CVTX) (Jobs) Drug Safety     9/5/2007
Sandoz Pharma A.G. Launches Generic Version Of Toprol XL(R) 50 Mg ER Tablet     8/3/2007
FDA Grants Fast Track Designation to Cardium Therapeutics, Inc. (CDTP.OB)'s Phase 3 Angiogenic Gene Therapy for Heart Disease     7/18/2007
CV Therapeutics, Inc. (CVTX) Angina Drug Fails in New Heart Disease Test     3/7/2007
NovaDel Pharma (NVD) Receives FDA Approval Of NitroMist(TM)     11/3/2006
CV Therapeutics, Inc. (CVTX) Acquires Rights To Ranolazine In Asia     6/22/2006
Corautus Genetics Inc. (VEGF) Halts Phase 2 Angina Clinical Trial; Stock Falls     4/10/2006
Boston Scientific Corporation (BSX) And Corautus Genetics Inc. (VEGF) Halt Phase IIb Chest Pain Trial     3/14/2006
Renovis, Inc. (RNVS) Announces Expansion Of SAINT II Phase III Trial With CEROVIVE(R); AstraZeneca (AZN) To Invest Significant Additional Resources     7/28/2005

News from Around the Web
Family Stress Linked to Angina Pain, Study Published in Journal of Epidemiology and Community Health     12/27/2010
Seven Hours The Magic Number For Sleep: West Virginia University Study     9/24/2010
Severe Angina Poses Three Times the Coronary Artery Disease Risk for Women Than Men, McMaster University Study     7/12/2010
Gout Drug Effective for Angina, University of Dundee Study     6/8/2010
Stem Cell Injections Seem to Reduce Angina Pain, Northwestern University Study     3/31/2009
Proteins That Stop A Major Signaling Pathway Can Also Generate New Proteins, Duke University Medical Center Study     4/25/2008
Depression More Damaging Than Some Chronic Illnesses     9/7/2007
Restricting Arm's Blood Flow May Protect the Heart     8/17/2007
Northwestern University's First Study Transplanting Angina Patients' Purified Stem Cells Shows Safety and Symptom Relief     6/27/2007
UNC Study Finds Link Between Migraines And The Chest Pain Angina     12/28/2004
Vibrating Trousers To Prevent Pain?     10/4/2004
QRxPharma In Hunt For Drugs In Reptiles' Venom     9/20/2004
Study: Bayer Drug Prevents Heart Attack, Stroke     8/30/2004
Fat Cells May Treat Heart Disease     3/8/2004
Drug Combo Cuts Death Risk For Heart Patients     2/17/2004

Press Releases
Positive Results For Neovasc (NVC)'s Reducer System Treatment For Refractory Angina Published In Cardiology Journal     6/20/2016
Inherited Herpes Virus Increases The Risk Of Angina Reports HHV-6 Foundation     7/7/2015
Cryopraxis Release: Cardiac Cell Therapy Phase III Trial to Treat Refractory Angina     11/6/2012
NJBIZ Names GENEWIZ, Inc. 2011 Business of the Year     12/7/2011
Baxter International, Inc. (BAX) Release: Phase Two Study Suggests Use of Adult Autologous Stem Cells May Improve Cardiac Function in Angina Patients     7/8/2011
Aldagen, Inc. (ALDH) Announces Publication of Phase 1/2 Results for ALD-301, a Stem Cell Therapy in Development for Critical Limb Ischemia     5/19/2011
Aldagen, Inc. (ALDH) Announces FDA Clearance of IND to Begin Phase 2 Study in Ischemic Stroke With Regenerative Cell Therapy     1/5/2011
Sun Pharmaceutical Industries Ltd Announces US FDA Approval for Generic Diltiazem ER(R)     11/18/2010
Tasly Pharmaceutical to Start Phase III Trial of TCM Angina Treatment in US     8/9/2010
Trophos Publishes The Identification And Characterization Of The Novel Cardioprotective Compound, TRO40303     7/28/2010
Gilead Sciences, Inc. (GILD) Announces Notification of ANDA Filing for Ranexa(R)     6/11/2010
Ark Therapeutics Release: EG011 (Refractory Angina) Demonstrates Ability To Grow New Blood Vessels And Restore Heart Function Following Heart Attack     6/19/2008
European Medicines Agency Adopts Positive Opinion for CV Therapeutics, Inc. (CVTX)'s Ranolazine for Treatment of Chronic Angina     4/25/2008
CV Therapeutics, Inc. (CVTX)'s Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina     4/2/2008
Pfizer Inc. (PFE) Release: Lipitor Provided an Unexpectedly Potent Heart Benefit in Patients with Chronic Stable Angina, According to New Study     4/1/2008

//-->